Home > Press > Diagnostic Testing, Medical Imaging and Pharmaceutical Markets to See Dramatic Growth
Abstract:
TriMarkPublications.com cites in its newly updated market research report bundles that the diagnostic testing, medical imaging and pharmaceutical markets will see dramatic growth. For more information, visit: www.trimarkpublications.com/categories/Report-Bundles.
The Cancer Reports Bundle covers:
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Cancer Cell Therapy
Cancer Diagnostic Testing
Cancer Therapeutics
Cancer Vaccines
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Cytology and HPV Testing
Game Changers in Breast Cancer Therapies
Molecular Diagnostics in Cancer Testing
The Diagnostics Reports Bundle covers:
Cancer Diagnostic Testing
Cardiac Marker Diagnostic Testing
Companion Diagnostics in Personalized Medicine and Cancer Therapy
European Point of Care (POC) Diagnostic Testing
High-Growth Diagnostic Testing
Key Diagnostic Testing
Molecular Diagnostics in Cancer Testing
Molecular Diagnostics in Infectious Disease Testing
Molecular Diagnostics
Over-the-Counter (OTC) Diagnostic Products
POC Diagnostic Testing Sector Trends
POC Diagnostic Testing
Women's Health Diagnostic Testing
The Genetics Reports Bundle covers:
Bioinformatics
DNA Sequencing and PCR
Gene Expression Reagents
Genomics
Microarray
Personalized Medicine
Pharmacogenomics for Clinical Use and in Drug Development
Regenerative Medicine
RNA Interference
Stem Cell
The Medical Devices Reports Bundle covers:
Cardiac Rhythm Management Devices
Catheter
Disposable Medical Supplies
Disposable Syringe
Home Medical Testing Devices
Orthopedics
Patient Monitoring
Plastic Surgery
Respiratory Therapeutics and Devices
Sleep Disorders
The Medical Imaging Reports Bundle covers:
European Medical Imaging
Mammography
Medical Imaging
Nuclear Cardiology
Picture Archiving and Communications Systems (PACS)
Positron Emission Tomography (PET)
Ultrasound
The Molecular Diagnostics Reports Bundle covers:
Molecular Diagnostics in Cancer Testing
Molecular Diagnostics in Infectious Disease Testing
Molecular Diagnostics
The Pharmaceuticals Reports Bundle covers:
Anti-Infective Drugs
Cell Therapy
Cell-Based Assays for Drug Discovery
Companion Biomarkers in Drug Development
Indian Pharmaceutical Industry
Medical Nanotechnology
Pharmacogenomics for Clinical Use and in Drug Development
Therapeutic Monoclonal Antibodies
The Cancer, Diagnostics, Genetics, Medical Devices, Medical Imaging, Molecular Diagnostics and Pharmaceuticals Report Bundles examine companies manufacturing cancer, diagnostics, genetics, medical device, medical imaging, molecular diagnostics and pharmaceutical equipment and supplies in the world. Companies covered include: 3M, Abbott, AstraZeneca, Bain, Bayer, Bayer, BD, Beckman Coulter, Bio-Rad, Bristol-Myers Squibb, Canon, Carl Zeiss, ETRI, FUJIFILM, Fujirebio, GE, Hitachi, Intel, Invitrogen, Johnson & Johnson, L.E.K., LG, Luminex, McKinsey, Novartis, Olympus, OraSure, Panasonic, PerkinElmer, Philips, QIAGEN, Roche, Rosetta, Samsung, Seventh Sense, Siemens, Sony, Sysmex and Toray.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: www.trimarkpublications.com/categories/Report-Bundles.
####
About TriMarkPublications.com
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing.
For more information, please click here
Contacts:
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||